免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料，僅供一般參考，不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Vercise™ DBS Dystonia Prospective Study

NCT：NCT02686125 · RECRUITING

NCT IDNCT02686125

狀態RECRUITING

開始日期2016-03-07

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2016-02-19

Last updated2026-09-11

簡要摘要

To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑